Aim: Relative assessment and relationship between of platelet aggregation and the level of interleukins IL-1β, IL-4, IL-6, and IL-18 among ischemic stroke (IS) patients. Methods: A prospective clinical cohort study involved 108 IS patients, classified into group 1—surviving (93; 86.1%) and group 2—lethal outcomes (15; 13.9%). The studies were conducted in the most acute (first day of hospitalization) and acute (7days of hospitalization) phases of IS. The level of interleukins was defined by enzyme immunoassay method.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...